Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about Copy of Newspaper Publication regarding Pre-AGM Notice of 11th Annual General Meeting to be on Monday, September 28, 2026, through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue growth of 9.1% year-on-year to ₹19.4 crores, and reported EBITDA and PAT of ₹2.4 crores and ₹1.8 crores respectively.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about the audio recording of the Earnings Call on the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has published unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation, with certain corrections and additional disclosures incorporated in the Revised Investor Presentation submitted earlier.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations, detailing the utilization of proceeds from its Initial Public Offer (IPO). The report indicates no deviation from the objects of the issue, with no range of deviation from the amount of issue proceeds earmarked for objects.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue growing 9.1% YoY to ₹19.4 Cr, EBITDA declining 52.96% YoY to ₹2.4 Cr, and PAT declining 42.27% YoY to ₹1.8 Cr. The company has also commenced operations at its new IVF Centre/Hub at South Extension, New Delhi, and approved the establishment of 'Gaudium Women Hospital, Lucknow'.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, including unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, re-appointment of internal auditor, appointment of secretarial auditor, and statement of deviation(s) or variation(s) regarding the utilization of funds raised through Initial Public Offer (IPO) for the quarter ended June 30, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding Change in Auditors of the company.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding Change in Auditors of the company. The Board of Directors has approved the Re-appointment of Ram Rattan & Associates as the Internal Auditor of the Company for the Financial Year 2026-27 and the appointment of M/s. Suresh Nainwal & Company as a Secretarial Auditor of the Company for a term of 5 (five) consecutive years.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has approved the re-appointment of Ram Rattan & Associates as the Internal Auditor, appointment of M/s. Suresh Nainwal & Company as a Secretarial Auditor, and the statement of Deviation(s) or Variation(s) regarding the utilization of funds raised through Initial Public Offer.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about the schedule of a meet to discuss the Q1 FY27 earnings, to be held on August 14, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited, India's first listed IVF company, has launched its first milestone in a planned 19-centre expansion, unveiling its AI-powered Signature Labs in South Delhi. The new centre combines AI-assisted embryology, globally benchmarked laboratory standards, and 17 years of fertility experience to provide high-quality, technology-driven fertility care to aspiring parents.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange about the commencement of commercial operations at its new IVF Centre/Hub at South Extension, New Delhi, with effect from July 16, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, stating that the regulation is not applicable to the company as all shares are in demat form and no requests for rematerialisation or dematerialization were received during the quarter.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the announcement of unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has submitted a corrigendum to its financial results for the quarter and year ended March 31, 2026, correcting inadvertent regrouping and typographical errors in the comparative figures for the previous financial year ended March 31, 2025.

Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited has informed the Exchange regarding Board Meeting Outcome for Approval For Setting Up Of Gaudium Women Hospital At Lucknow, Uttar Pradesh. The Board of Directors approved the proposal for establishment, development, operation and management of "Gaudium Women Hospital, Lucknow" at the property situated in Lucknow, Uttar Pradesh, through a long-term arrangement with the owner of the said property.

Gaudium IVF and Women Health Limited

Dr. Manika Khanna, a promoter of Gaudium IVF and Women Health Limited, has submitted a disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the Promoter and Promoter Group did not create any encumbrances (pledges) on the company's shares, either directly or indirectly, during the financial year ended March 31, 2026. This annual declaration reassures stakeholders regarding the stability of promoter shareholding.